S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
What Should Investors Make of These 3 Dividend Cuts?
We Called (ARWR) In Advance, Which Stocks Are Next? (Ad)
CrowdStrike: Another Tech Stock to Buy on the Dip 
Trading Channel Breakout in Lululemon Brought by Earnings
We Called (ARWR) In Advance, Which Stocks Are Next? (Ad)
Constellation Brands Taps into Growth: Analysts Bullish on Stock
Salesforce: Time to Snap it Up as the Market Buys the Dip?
We Called (ARWR) In Advance, Which Stocks Are Next? (Ad)
Zscaler: Analysts Raise the Bar for the AI Cloud Security Company
MarketBeat Week in Review – 5/29 - 6/2
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
What Should Investors Make of These 3 Dividend Cuts?
We Called (ARWR) In Advance, Which Stocks Are Next? (Ad)
CrowdStrike: Another Tech Stock to Buy on the Dip 
Trading Channel Breakout in Lululemon Brought by Earnings
We Called (ARWR) In Advance, Which Stocks Are Next? (Ad)
Constellation Brands Taps into Growth: Analysts Bullish on Stock
Salesforce: Time to Snap it Up as the Market Buys the Dip?
We Called (ARWR) In Advance, Which Stocks Are Next? (Ad)
Zscaler: Analysts Raise the Bar for the AI Cloud Security Company
MarketBeat Week in Review – 5/29 - 6/2
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
What Should Investors Make of These 3 Dividend Cuts?
We Called (ARWR) In Advance, Which Stocks Are Next? (Ad)
CrowdStrike: Another Tech Stock to Buy on the Dip 
Trading Channel Breakout in Lululemon Brought by Earnings
We Called (ARWR) In Advance, Which Stocks Are Next? (Ad)
Constellation Brands Taps into Growth: Analysts Bullish on Stock
Salesforce: Time to Snap it Up as the Market Buys the Dip?
We Called (ARWR) In Advance, Which Stocks Are Next? (Ad)
Zscaler: Analysts Raise the Bar for the AI Cloud Security Company
MarketBeat Week in Review – 5/29 - 6/2
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
What Should Investors Make of These 3 Dividend Cuts?
We Called (ARWR) In Advance, Which Stocks Are Next? (Ad)
CrowdStrike: Another Tech Stock to Buy on the Dip 
Trading Channel Breakout in Lululemon Brought by Earnings
We Called (ARWR) In Advance, Which Stocks Are Next? (Ad)
Constellation Brands Taps into Growth: Analysts Bullish on Stock
Salesforce: Time to Snap it Up as the Market Buys the Dip?
We Called (ARWR) In Advance, Which Stocks Are Next? (Ad)
Zscaler: Analysts Raise the Bar for the AI Cloud Security Company
MarketBeat Week in Review – 5/29 - 6/2
NASDAQ:ACCD

Accolade (ACCD) Stock Forecast, Price & News

$13.07
+0.59 (+4.73%)
(As of 06/2/2023 ET)
Compare
Today's Range
$12.42
$13.07
50-Day Range
$10.52
$16.06
52-Week Range
$5.24
$17.00
Volume
489,002 shs
Average Volume
588,398 shs
Market Capitalization
$962.34 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$14.74

Accolade MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.69 Rating Score
Upside/​Downside
12.7% Upside
$14.74 Price Target
Short Interest
Healthy
4.97% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.85
Upright™ Environmental Score
News Sentiment
-0.08mentions of Accolade in the last 14 days
Based on 9 Articles This Week
Insider Trading
Selling Shares
$145,556 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($1.89) to ($1.64) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.37 out of 5 stars

Business Services Sector

101st out of 339 stocks

Business Services, Not Elsewhere Classified Industry

36th out of 91 stocks


ACCD stock logo

About Accolade (NASDAQ:ACCD) Stock

Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was incorporated in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.

Receive ACCD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Accolade and its competitors with MarketBeat's FREE daily newsletter.

ACCD Stock News Headlines

"Unknown laser company making HUGE profit from Russia-Ukraine War"
On February 24th, Russia invaded Ukraine. This caused major stock losses and soaring gas prices. But it also created a HUGE opportunity for savvy investors. There's an unknown laser company that's been profiting greatly from this war... ...and from another major conflict happening 3,000 miles away. Learn more here >>>
Accolade (NASDAQ:ACCD) Raised to Buy at Bank of America
"Unknown laser company making HUGE profit from Russia-Ukraine War"
On February 24th, Russia invaded Ukraine. This caused major stock losses and soaring gas prices. But it also created a HUGE opportunity for savvy investors. There's an unknown laser company that's been profiting greatly from this war... ...and from another major conflict happening 3,000 miles away. Learn more here >>>
ACCD Jun 2024 12.500 put
Accolade Announces Upcoming Investor Events
Accolade (NASDAQ:ACCD) Price Target Raised to $16.00
Accolade (NASDAQ:ACCD) Stock Price Down 2.8%
Accolade (NASDAQ:ACCD) PT Raised to $18.00
Accolade (ACCD) to Release Quarterly Earnings on Thursday
Accolade to Webcast Analyst Day on May 8, 2023
See More Headlines

ACCD Price History

ACCD Company Calendar

Last Earnings
4/27/2023
Today
6/02/2023
Next Earnings (Estimated)
6/29/2023
Fiscal Year End
2/29/2024

Industry, Sector and Symbol

Industry
Business services, not elsewhere classified
Sub-Industry
N/A
Current Symbol
NASDAQ:ACCD
Fax
N/A
Employees
2,370
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$14.74
High Stock Price Forecast
$18.00
Low Stock Price Forecast
$11.00
Forecasted Upside/Downside
+12.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.69
Research Coverage
16 Analysts

Profitability

Net Income
$-459,650,000.00
Net Margins
-126.58%
Pretax Margin
-127.57%

Debt

Sales & Book Value

Annual Sales
$363.14 million
Book Value
$6.51 per share

Miscellaneous

Free Float
68,259,000
Market Cap
$962.34 million
Optionable
Not Optionable
Beta
1.70

Key Executives

  • Mr. Rajeev Singh (Age 55)
    Chairman & CEO
    Comp: $847.24k
  • Mr. Robert Cavanaugh (Age 54)
    Pres
    Comp: $644.93k
  • Mr. Stephen H. Barnes CPA (Age 51)
    CFO & Treasurer
    Comp: $602.66k
  • Mr. Michael W. Hilton (Age 58)
    Chief Innovation Officer
    Comp: $598.39k
  • Mr. Todd Friedman
    Sr. VP of Investor Relations
  • Mr. Richard Eskew
    EVP, Gen. Counsel, CCO & Sec.
  • Ms. Carolina Lobo
    Chief Marketing Officer
  • Ms. Kristen Keating Weeks
    Sr. VP of Strategy, Corp. Devel. & Partnerships
  • Ms. Jennifer Hanson
    Exec. VP of People and Culture & Chief HR Officer
  • Mr. Todd Clardy
    Exec. VP & GM of Mid-Market Bus.













ACCD Stock - Frequently Asked Questions

Should I buy or sell Accolade stock right now?

16 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Accolade in the last twelve months. There are currently 5 hold ratings and 11 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ACCD shares.
View ACCD analyst ratings
or view top-rated stocks.

What is Accolade's stock price forecast for 2023?

16 brokerages have issued 12 month target prices for Accolade's shares. Their ACCD share price forecasts range from $11.00 to $18.00. On average, they predict the company's share price to reach $14.74 in the next year. This suggests a possible upside of 12.7% from the stock's current price.
View analysts price targets for ACCD
or view top-rated stocks among Wall Street analysts.

How have ACCD shares performed in 2023?

Accolade's stock was trading at $7.79 on January 1st, 2023. Since then, ACCD stock has increased by 67.8% and is now trading at $13.07.
View the best growth stocks for 2023 here
.

When is Accolade's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, June 29th 2023.
View our ACCD earnings forecast
.

How were Accolade's earnings last quarter?

Accolade, Inc. (NASDAQ:ACCD) announced its earnings results on Thursday, April, 27th. The company reported ($0.42) earnings per share for the quarter, topping the consensus estimate of ($0.43) by $0.01. The company had revenue of $99.03 million for the quarter, compared to analyst estimates of $99.44 million. Accolade had a negative net margin of 126.58% and a negative trailing twelve-month return on equity of 31.98%. Accolade's quarterly revenue was up 5.6% compared to the same quarter last year. During the same period in the previous year, the business earned ($0.59) earnings per share.

What guidance has Accolade issued on next quarter's earnings?

Accolade updated its first quarter 2024 earnings guidance on Thursday, April, 27th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $89.00 million-$91.00 million, compared to the consensus revenue estimate of $94.51 million.

What is Rajeev Singh's approval rating as Accolade's CEO?

152 employees have rated Accolade Chief Executive Officer Rajeev Singh on Glassdoor.com. Rajeev Singh has an approval rating of 74% among the company's employees.

What other stocks do shareholders of Accolade own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Accolade investors own include CVS Health (CVS), Johnson & Johnson (JNJ), Raytheon Technologies (RTX), Alibaba Group (BABA), Home Depot (HD), Procter & Gamble (PG), Thermo Fisher Scientific (TMO), Cisco Systems (CSCO) and Intel (INTC).

When did Accolade IPO?

(ACCD) raised $176 million in an IPO on Thursday, July 2nd 2020. The company issued 8,800,000 shares at $19.00-$21.00 per share. Goldman Sachs, Morgan Stanley and BofA Securities acted as the underwriters for the IPO and Piper Sandler, Credit Suisse, William Blair, Baird and SVB Leerink were co-managers.

What is Accolade's stock symbol?

Accolade trades on the NASDAQ under the ticker symbol "ACCD."

Who are Accolade's major shareholders?

Accolade's stock is owned by many different retail and institutional investors. Top institutional shareholders include JPMorgan Chase & Co. (8.00%), ARK Investment Management LLC (7.88%), Brown Advisory Inc. (6.98%), Sepio Capital LP (2.05%), State Street Corp (2.04%) and Geode Capital Management LLC (1.77%). Insiders that own company stock include Michael W Hilton, Rajeev Singh, Richard Eskew, Robert N Cavanaugh, Stephen H Barnes and Thomas J Neff.
View institutional ownership trends
.

How do I buy shares of Accolade?

Shares of ACCD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Accolade's stock price today?

One share of ACCD stock can currently be purchased for approximately $13.07.

How much money does Accolade make?

Accolade (NASDAQ:ACCD) has a market capitalization of $962.34 million and generates $363.14 million in revenue each year. The company earns $-459,650,000.00 in net income (profit) each year or ($6.56) on an earnings per share basis.

How many employees does Accolade have?

The company employs 2,370 workers across the globe.

How can I contact Accolade?

Accolade's mailing address is 660 W. GERMANTOWN PIKE SUITE 500, PLYMOUTH MEETING PA, 19462. The official website for the company is accolade.com. The company can be reached via phone at 206-926-8100 or via email at ir@accolade.com.

This page (NASDAQ:ACCD) was last updated on 6/3/2023 by MarketBeat.com Staff

My Account -